Evidence map›Paper›PMID 30736279›Full record

ArticleInternational journal of molecular sciences2019

Quantifying

Vanessa L Lattimore, John F Pearson, Arthur E Morley-Bunker, kConFab Investigators, Amanda B Spurdle, Bridget A Robinson, Margaret J Currie, Logan C Walker

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Vanessa L LattimoreDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. vanessa.lattimore@otago.ac.nz.ORCID 0000-0002-5374-1035
John F PearsonDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. john.pearson@otago.ac.nz.
Arthur E Morley-BunkerDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. morar032@student.otago.ac.nz.
kConFab InvestigatorsResearch Department, Peter MacCallum Cancer Center, Melbourne 3010, Australia. heather.thorne@petermac.org.
Amanda B SpurdleGenetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queenslan 4006, Australia. amanda.Spurdle@qimrberghofer.edu.au.
Bridget A RobinsonDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. bridget.robinson@cdhb.health.nz.ORCID 0000-0001-9483-9146
Margaret J CurrieDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. margaret.currie@otago.ac.nz.
Logan C WalkerDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. logan.walker@otago.ac.nz.
University of Otago · NZChristchurch Hospital · NZQIMR Berghofer Medical Research Institute · AUThe University of Melbourne · AU

Funding

Health Research Council of New Zealand 12/799
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alternative SplicingRNA, MessengerAllelesBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsCell Line, TumorFemaleGenotypeHumansSingle-Cell AnalysisBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanRNA, MessengerBRCA1BRCA2mRNA expressionRNAscopesingle cellsplicing

Identifiers

PMID30736279
PMCPMC6387195
OpenAlexW2912370785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.